Tokai Pharmaceuticals CFO Paul Little's 2021 pay jumps 156% to $2.2M
Tokai Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Tokai Pharmaceuticals reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at Tokai Pharmaceuticals received on average a compensation package of $1.5M, a 80% decrease compared to previous year.
Average pay of disclosed executives at Tokai Pharmaceuticals
Paul Little, Chief Financial Officer, received $2.2M in total. 85% of Little's compensation, or $1.9M, was in option awards. Little also received $323K in salary and $1.3K in other compensation.
Bryan Smith, General Counsel, received a compensation package of $1.7M. 78% of the compensation package, or $1.3M, was in option awards.
David-Alexandre C. Gros, Chief Executive Officer, earned $604K in 2021, a 92% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.